- Home
- ADPT vs THR Comparison
ADPT vs THR Comparison
Compare ADPT & THR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADPT
- THR
- Stock Information
- Founded
- ADPT 2009
- THR 1954
- Country
- ADPT United States
- THR United States
- Employees
- ADPT N/A
- THR N/A
- Industry
- ADPT Biotechnology: Biological Products (No Diagnostic Substances)
- THR Industrial Machinery/Components
- Sector
- ADPT Health Care
- THR Energy
- Exchange
- ADPT Nasdaq
- THR Nasdaq
- Market Cap
- ADPT 1.8B
- THR 906.5M
- IPO Year
- ADPT 2019
- THR 2011
- Fundamental
- Price
- ADPT $11.82
- THR $28.17
- Analyst Decision
- ADPT Strong Buy
- THR
- Analyst Count
- ADPT 7
- THR 0
- Target Price
- ADPT $10.57
- THR N/A
- AVG Volume (30 Days)
- ADPT 2.4M
- THR 155.8K
- Earning Date
- ADPT 07-31-2025
- THR 08-06-2025
- Dividend Yield
- ADPT N/A
- THR N/A
- EPS Growth
- ADPT N/A
- THR 3.97
- EPS
- ADPT N/A
- THR 1.57
- Revenue
- ADPT $189,527,000.00
- THR $498,207,000.00
- Revenue This Year
- ADPT $24.46
- THR $6.11
- Revenue Next Year
- ADPT $20.25
- THR $5.40
- P/E Ratio
- ADPT N/A
- THR $18.13
- Revenue Growth
- ADPT 8.61
- THR 0.72
- 52 Week Low
- ADPT $3.51
- THR $23.05
- 52 Week High
- ADPT $12.43
- THR $34.36
- Technical
- Relative Strength Index (RSI)
- ADPT 63.35
- THR 52.07
- Support Level
- ADPT $11.41
- THR $28.12
- Resistance Level
- ADPT $12.36
- THR $28.94
- Average True Range (ATR)
- ADPT 0.59
- THR 0.71
- MACD
- ADPT -0.01
- THR 0.03
- Stochastic Oscillator
- ADPT 72.65
- THR 55.47
About ADPT Adaptive Biotechnologies Corporation
Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease (MRD) in patients with multiple myeloma (MM), B cell acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia (CLL) and is also available as a CLIA-validated laboratory developed test (LDT) for patients with other lymphoid cancers, including diffuse large B-cell lymphoma (DLBCL).
About THR Thermon Group Holdings Inc.
Thermon Group Holdings Inc is a United States-based company that provides engineered industrial process heating solutions for process industries. It offers a full suite of products (heating units, electrode and gas-fired boilers, heating cables, industrial heating blankets and related products, temporary power solutions and tubing bundles), services (engineering, installation and maintenance services) and software (design optimization and wireless and network control systems) required to deliver comprehensive solutions to some of the world's Large and most complex projects. Its products and services include a wide range of electric heat tracing cables, steam heating solutions, controls, monitoring and software, instrumentation, project services, industrial heating and filtration solutions.